217 related articles for article (PubMed ID: 31403365)
1. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD.
Uzan GC; Borekci S; Doventas YE; Koldas M; Gemicioglu B
J Asthma; 2020 Dec; 57(12):1273-1279. PubMed ID: 31403365
[No Abstract] [Full Text] [Related]
2. Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome.
Ding Q; Sun S; Zhang Y; Tang P; Lv C; Ma H; Yu Y; Xu S; Deng Z
Int J Chron Obstruct Pulmon Dis; 2020; 15():357-365. PubMed ID: 32103934
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
Albertson TE; Chenoweth JA; Pearson SJ; Murin S
Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
[No Abstract] [Full Text] [Related]
4. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.
Huang AX; Lu LW; Liu WJ; Huang M
Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772
[TBL] [Abstract][Full Text] [Related]
5. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
6. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
7. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach.
Inoue H; Nagase T; Morita S; Yoshida A; Jinnai T; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1803-1810. PubMed ID: 28694693
[TBL] [Abstract][Full Text] [Related]
9. Radiographic Evidence of Sinonasal Inflammation in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: An Underrecognized Association.
Hamada S; Tatsumi S; Kobayashi Y; Matsumoto H; Yasuba H
J Allergy Clin Immunol Pract; 2017; 5(6):1657-1662. PubMed ID: 28460847
[TBL] [Abstract][Full Text] [Related]
10. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
11. Differences between asthma-COPD overlap syndrome and adult-onset asthma.
Tommola M; Ilmarinen P; Tuomisto LE; Lehtimäki L; Haanpää J; Niemelä O; Kankaanranta H
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461298
[TBL] [Abstract][Full Text] [Related]
12. Comparison of therapeutic response between asthma, COPD, and ACOS patients by evaluation of spirometric findings.
Hejazi ME; Pakzad Z; Shojaan H; Kalami N; Hejazi V; Vaezi T
J Popul Ther Clin Pharmacol; 2022; 29(4):e195-e201. PubMed ID: 36481989
[TBL] [Abstract][Full Text] [Related]
13. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
14. [Asthma-chronic obstructive pulmonary disease overlap syndrome: clinical-functional profile].
Che-Morales JL; Valle-Piña J; Carrillo-Chan J
Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):284-290. PubMed ID: 32568483
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
16. Childhood Lung Function Predicts Adult Chronic Obstructive Pulmonary Disease and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.
Bui DS; Burgess JA; Lowe AJ; Perret JL; Lodge CJ; Bui M; Morrison S; Thompson BR; Thomas PS; Giles GG; Garcia-Aymerich J; Jarvis D; Abramson MJ; Walters EH; Matheson MC; Dharmage SC
Am J Respir Crit Care Med; 2017 Jul; 196(1):39-46. PubMed ID: 28146643
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of asthma and COPD overlap syndrome (ACOS) in the Canadian population.
Senthilselvan A; Beach J
J Asthma; 2019 Nov; 56(11):1129-1137. PubMed ID: 30359154
[No Abstract] [Full Text] [Related]
18. Decreased concentration of IL-35 in plasma of patients with asthma and COPD.
Chen C; Deng Y; Chen H; Wu X; Cheng S; Xu Y; Xiong W; Xie J
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):211-7. PubMed ID: 25268338
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
20. The Plasma Levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in Patients with Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS).
Bersimbaev R; Aripova A; Bulgakova O; Kussainova А; Akparova A; Izzotti A
Microrna; 2021; 10(2):130-138. PubMed ID: 34151771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
